Assessing the economic impact of healthcare policies, regulations, and public health interventions
Public policies and regulations can have a significant impact on the structure, conduct, and performance of many industries, especially the U.S. and global health industries. AHE’s capability in Policy & Regulatory Analysis focuses on the impact of healthcare policies and regulations on costs and outcomes and, more broadly, the impact of healthcare and public health interventions on measures of cost, quality, and outcomes. Our team’s broad experience and training in economic analysis and evaluation has been applied to issues regarding organizational change, program effectiveness, economic impact, healthcare training and staffing, regulatory cost-benefit analysis, environmental impact, and simulation analyses of healthcare laws and regulations. Our work products have been used to support policy debates at the city, state, and federal levels. For example, at the federal level, our work has been used to support deliberations by the U.S. House of Representatives Committee on Ways and Means and the U.S. Congressional Budget Office. We have also worked directly with global organizations, including the World Health Organization, on worldwide health issues. Similar to our other practice areas, the common thread is the intersection of rigorous data analysis and modelling with practical and meaningful real-world applications.
Our specific core capabilities include:
Cost-benefit analysis is a commonly used tool to assess the net impact of laws and regulations, expressed monetarily.
Economic impact analyses calculate the primary and secondary benefits of a business activity or an expenditure, typically using a "multiplier".
Economic externalities are either positive or negative secondary effects associated with a transaction or production; for example, a consequence of an industrial or commercial activity that affects other parties without being reflected in the cost of the goods or services involved. Attributable costs are the damages or costs attributable directly to harms and externalities.
Total costs or net costs that are attributable directly to a specific law or regulation.
Total costs that are necessary to remedy, mitigate, or abate all or some portion of an externality, harm, or public nuisance.
Collecting, analyzing, and using information to assess the effectiveness, efficiency, and impact of projects, policies, and programs.
Research and analysis to support government communication and advocacy.
Creation of effective and novel communication materials is critical to conveying value propositions to key stakeholders.
Creation of effective and novel communication materials is critical to conveying value propositions to key stakeholders.
Our academic roots make education and training second nature for us, and we recognize knowledge transfer to clients and stakeholders is critical to achieving organizational and strategic goals.
We serve a wide variety of clients throughout the U.S. and globally, including professional organizations, trade associations, non-profit organizations, and departments and agencies within city, state, and federal government. We have worked on behalf of a wide variety of organizations, ranging from professional medical societies (for example, the American Society of Anesthesiologists, Physician-Led Healthcare for America, the American Optometric Association, and the National Kidney Foundation).
Examples of engagements include:

A study by J. Schneider, P. Li, and R. Ohsfeldt published in the journal Contemporary Economic Policy (2010) examined the effect of physician-owned hospitals (POHs) on Medicare per enrollee expenditures at the metropolitan area (MSA) level nationwide, spanning the 8-year time period from 1998 to 2005. The working hypothesis was that physician ownership may increase utilization and expenditures through demand inducement. The study used fixed effects panel data regression with instrumental variables to account for the potential bias introduced by endogenous POH market entry (i.e., POHs may be more likely to open in high-growth/high-demand markets with high levels of Medicare per enrollee expenditures).
Read more...